相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)
James A. Karlowsky et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis
Annie J. Browne et al.
BMC MEDICINE (2020)
Fourth Generation Cephalosporin Resistance Among Salmonella enterica Serovar Enteritidis Isolates in Shanghai, China Conferred by blaCTX-M-55 Harboring Plasmids
Ying Fu et al.
FRONTIERS IN MICROBIOLOGY (2020)
Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from US medical centres
Elizabeth B. Hirsch et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Drug resistance in Salmonella Typhi: implications for South Asia and travel
Sneha Radha et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
In vitro susceptibility of Salmonella enterica serovar Typhi to ceftolozane/tazobactam
Elaine Chan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin
Wonhee So et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Characteristics of cephalosporin-resistant Salmonella isolates from poultry in Korea, 2010-2017
Hye Young Jeon et al.
POULTRY SCIENCE (2019)
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from US Hospitals
Mariana Castanheir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar
Mazen A. Sid Ahmed et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Emergence and Evolution of High-Level Cephalosporin-Resistant Salmonella Goldcoast in Northern Taiwan
Ye Feng et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
A systematic review of antimicrobial resistance of typhoidal Salmonella in India
Carl D. Britto et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
Pablo A. Fraile-Ribot et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
Ryan K. Shields et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
In Vitro Susceptibility of Ceftolozane-Tazobactam against Burkholderia pseudomallei
Elaine Chan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
High prevalence of ceftriaxone resistance among invasive Salmonella enterica serotype Choleraesuis isolates in Thailand: The emergence and increase of CTX-M-55 in ciprofloxacin-resistant S. Choleraesuis isolates
Sirirat Luk-in et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing
Wim L. Cuypers et al.
MICROBIAL GENOMICS (2018)
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Whole-Genome Shotgun Sequencing of Cephalosporin-Resistant Salmonella enterica Serovar Typhi
Camilla Rodrigues et al.
GENOME ANNOUNCEMENTS (2017)
Antimicrobial Resistance in Salmonella in the United States from 1948 to 1995
Daniel A. Tadesse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Characterization of Salmonella Isangi possessing a CTX-M15 ESBL associated with an outbreak in a US Hospital
Geehan Suleyman et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Extended-Spectrum Cephalosporin-Resistant Salmonella enterica serovar Heidelberg Strains, the Netherlands
Apostolos Liakopoulos et al.
EMERGING INFECTIOUS DISEASES (2016)
Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects
Saeed Akhtar et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2015)
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Outbreak of Salmonella enterica serotype Infantis producing ArmA 16S RNA methylase and CTX-M-15 extended-spectrum β-lactamase in a neonatology ward in Constantine, Algeria
Thierry Naas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing Enterobacteriaceae
Silke Polsfuss et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
The Global Burden of Nontyphoidal Salmonella Gastroenteritis
Shannon E. Majowicz et al.
CLINICAL INFECTIOUS DISEASES (2010)
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus β-lactamase-producing Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae
Caroline Dallenne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Rising prevalence of enteric fever due to multidrug-resistant Salmonella:: an epidemiological study
Surinder Kumar et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates
Vincent O. Rotimi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance
Amber J. Schmidtke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)
DJ Biedenbach et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Nosocomial outbreak caused by Salmonella enterica serotype livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia
O Bouallègue-Godet et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Antimicrobial-resistant nontyphoidal salmonella is associated with excess bloodstream infections and hospitalizations
JK Varma et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
FJ Pérez-Pérez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis
CH Chiu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.
SJ Olsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
